Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (401-410 of 437) with videos related to

Pageof 44
Sort By:
Seminars in Arthritis and Rheumatism|November 23, 2023
Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes in ankylosing spondylitis cohortParas Karmacharya, Cynthia S Crowson, Ryan J Lennon, et al.
Science Advances|April 1, 2026
Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodiesXingxing Zhu, Yue Yu, Shiju Chen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2026
Reclassifying dropouts from antipsychotic trials due to study-reported adverse events: a systematic review and individual-participant-data meta-analysesYuki Furukawa, Spyridon Siafis, Johannes Schneider-Thoma, et al.
Journal of Autism and Developmental Disorders|November 25, 2022
Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center TrialJianjun Ou, Robert C Smith, Russell H Tobe, et al.
F1000Research|January 26, 2026
Sex differences in the efficacy and tolerability of antipsychotic drugs in people with an acute exacerbation of schizophrenia: protocol for an individual-participant-data, dose-response, network meta-analysisSpyridon Siafis, Yuki Furukawa, Johannes Schneider-Thoma, et al.
Contemporary Clinical Trials|July 16, 2025
Rationale and design of the rheumatoid arthritis non-responders to treatment (RANT) study: Use of a bioinformatics platform and "decentralized" clinical recruitment designGregory C McDermott, Mary Jeffway, Thany Seyok, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodiesXingxing Zhu, Yue Yu, Yanfeng Li, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 16, 2017
Derivation and Evaluation of Putative Adverse Outcome Pathways for the Effects of Cyclooxygenase Inhibitors on Reproductive Processes in Female FishDalma Martinovic-Weigelt, Alvine C Mehinto, Gerald T Ankley, et al.
European Journal of Endocrinology|February 18, 2025
Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humansFrancesca Galbiati, Franziska Plessow, Lacey Plummer, et al.
Nature Communications|July 19, 2014
Latent homology and convergent regulatory evolution underlies the repeated emergence of yeastsLászló G Nagy, Robin A Ohm, Gábor M Kovács, et al.
Pageof 44

Showing results (401-410 of 437) with videos related to

Sort By:
Pageof 44
Seminars in Arthritis and Rheumatism|November 23, 2023
Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes in ankylosing spondylitis cohortParas Karmacharya, Cynthia S Crowson, Ryan J Lennon, et al.
Science Advances|April 1, 2026
Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodiesXingxing Zhu, Yue Yu, Shiju Chen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2026
Reclassifying dropouts from antipsychotic trials due to study-reported adverse events: a systematic review and individual-participant-data meta-analysesYuki Furukawa, Spyridon Siafis, Johannes Schneider-Thoma, et al.
Journal of Autism and Developmental Disorders|November 25, 2022
Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center TrialJianjun Ou, Robert C Smith, Russell H Tobe, et al.
F1000Research|January 26, 2026
Sex differences in the efficacy and tolerability of antipsychotic drugs in people with an acute exacerbation of schizophrenia: protocol for an individual-participant-data, dose-response, network meta-analysisSpyridon Siafis, Yuki Furukawa, Johannes Schneider-Thoma, et al.
Contemporary Clinical Trials|July 16, 2025
Rationale and design of the rheumatoid arthritis non-responders to treatment (RANT) study: Use of a bioinformatics platform and "decentralized" clinical recruitment designGregory C McDermott, Mary Jeffway, Thany Seyok, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodiesXingxing Zhu, Yue Yu, Yanfeng Li, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 16, 2017
Derivation and Evaluation of Putative Adverse Outcome Pathways for the Effects of Cyclooxygenase Inhibitors on Reproductive Processes in Female FishDalma Martinovic-Weigelt, Alvine C Mehinto, Gerald T Ankley, et al.
European Journal of Endocrinology|February 18, 2025
Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humansFrancesca Galbiati, Franziska Plessow, Lacey Plummer, et al.
Nature Communications|July 19, 2014
Latent homology and convergent regulatory evolution underlies the repeated emergence of yeastsLászló G Nagy, Robin A Ohm, Gábor M Kovács, et al.
Pageof 44